icad Inc (ICAD)
1.46
+0.02
(+1.39%)
USD |
NASDAQ |
May 09, 14:02
icad Research and Development Expense (Quarterly): 1.252M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.252M |
| September 30, 2023 | 1.147M |
| June 30, 2023 | 1.263M |
| March 31, 2023 | 2.281M |
| December 31, 2022 | 1.134M |
| September 30, 2022 | 1.407M |
| June 30, 2022 | 2.367M |
| March 31, 2022 | 2.275M |
| December 31, 2021 | 2.449M |
| September 30, 2021 | 2.285M |
| June 30, 2021 | 2.268M |
| March 31, 2021 | 2.192M |
| December 31, 2020 | 2.176M |
| September 30, 2020 | 1.849M |
| June 30, 2020 | 1.878M |
| March 31, 2020 | 2.211M |
| December 31, 2019 | 2.52M |
| September 30, 2019 | 2.485M |
| June 30, 2019 | 2.139M |
| March 31, 2019 | 2.127M |
| December 31, 2018 | 2.014M |
| September 30, 2018 | 2.035M |
| June 30, 2018 | 2.057M |
| March 31, 2018 | 3.339M |
| December 31, 2017 | 2.267M |
| Date | Value |
|---|---|
| September 30, 2017 | 2.254M |
| June 30, 2017 | 2.232M |
| March 31, 2017 | 2.574M |
| December 31, 2016 | 2.683M |
| September 30, 2016 | 2.36M |
| June 30, 2016 | 2.204M |
| March 31, 2016 | 2.271M |
| December 31, 2015 | 2.542M |
| September 30, 2015 | 2.093M |
| June 30, 2015 | 2.272M |
| March 31, 2015 | 2.256M |
| December 31, 2014 | 2.207M |
| September 30, 2014 | 2.086M |
| June 30, 2014 | 2.004M |
| March 31, 2014 | 1.862M |
| December 31, 2013 | 1.799M |
| September 30, 2013 | 1.951M |
| June 30, 2013 | 1.756M |
| March 31, 2013 | 1.866M |
| December 31, 2012 | 0.873M |
| September 30, 2012 | 1.971M |
| June 30, 2012 | 1.975M |
| March 31, 2012 | 2.212M |
| December 31, 2011 | 2.081M |
| September 30, 2011 | 2.63M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
1.134M
Minimum
Dec 2022
2.52M
Maximum
Dec 2019
1.978M
Average
2.192M
Median
Mar 2021
Research and Development Expense (Quarterly) Benchmarks
| ClearPoint Neuro Inc | 2.652M |
| Perspective Therapeutics Inc | 6.08M |
| Xtant Medical Holdings Inc | 0.492M |
| Asensus Surgical Inc | 8.614M |
| Catheter Precision Inc | -0.011M |